(RTTNews) - U.S. biomarker diagnostics company Quanterix Corp. (QTRX) announced on Monday that it has appointed physician executive Yuri Fesko as Chief Medical Officer. Fesko will provide medical and clinical leadership across the company, as it prepares for the broader launch of its Lucent AD Complete Alzheimer's test and advances regulatory filings for its HD-X instrument. Fesko had previously served as Chief Medical Officer at Quest Diagnostics, overseeing medical affairs, clinical development and public health. On the Nasdaq, shares of Quanterix are currently losing 0.78 percent, changing hands at $2.5400 (RTTNews) - U.S. biomarker diagnostics company Quanterix Corp.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.